Treating Osteoporosis

Overview

Journal Aust Prescr

Date 2016 Jun 25

PMID 27340321

Citations 10

Authors

Akhil Gupta

Lyn March

Affiliations

Soon will be listed here.

Abstract

Osteoporotic fractures are common resulting in increased morbidity and mortality. Exercise can help prevent osteoporosis. It can also benefit patients with osteoporosis, but the exercises must be tailored to the patient. Most Australians should be able to obtain adequate calcium in their diet and vitamin D from the sun. Supplements may be needed in some patients and they are recommended for use with other drugs for osteoporosis. Bisphosphonates, and in some patients denosumab, are first-line drugs for osteoporosis. Raloxifene and strontium ranelate can be considered in patients who cannot take bisphosphonates or denosumab. Teriparatide is reserved for patients with severe osteoporosis and the use of strontium ranelate is declining because of cardiovascular safety concerns.

Citing Articles

Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older.

Kirk J, Rathbun A, Gruber-Baldini A, Hochberg M, Magaziner J, Shardell M Osteoporos Int. 2024; 35(11):1943-1950.

PMID: 39093438 PMC: 11886897. DOI: 10.1007/s00198-024-07211-4.

Osteoporosis management-current and future perspectives - A systemic review.

Anish R, Nair A J Orthop. 2024; 53:101-113.

PMID: 38495575 PMC: 10940894. DOI: 10.1016/j.jor.2024.03.002.

The effects of combined amplitude and high-frequency vibration on physically inactive osteopenic postmenopausal women.

Fernandez P, Pasqualini M, Locrelle H, Normand M, Bonneau C, Lafage Proust M Front Physiol. 2022; 13:952140.

PMID: 36160873 PMC: 9491321. DOI: 10.3389/fphys.2022.952140.

Zoledronic acid does not slow spinal radiographic progression of osteoarthritis in postmenopausal women with osteoporosis and radiographic osteoarthritis.

Host L, Keen H, Laslett L, Black D, Jones G Ther Adv Musculoskelet Dis. 2022; 14:1759720X221081652.

PMID: 35844267 PMC: 9283639. DOI: 10.1177/1759720X221081652.

Evaluating the Role of Probiotics in the Prevention and Management of Age-Related Diseases.

Kiousi D, Kouroutzidou A, Neanidis K, Matthaios D, Pappa A, Galanis A Int J Mol Sci. 2022; 23(7).

PMID: 35408987 PMC: 8999082. DOI: 10.3390/ijms23073628.

References

Bolland M, Avenell A, Baron J, Grey A, MacLennan G, Gamble G . Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010; 341:c3691. PMC: 2912459. DOI: 10.1136/bmj.c3691. View

Mursu J, Robien K, Harnack L, Park K, Jacobs Jr D . Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med. 2011; 171(18):1625-33. PMC: 4114071. DOI: 10.1001/archinternmed.2011.445. View

Bhutani G, Gupta M . Emerging therapies for the treatment of osteoporosis. J Midlife Health. 2014; 4(3):147-52. PMC: 3952405. DOI: 10.4103/0976-7800.118991. View

Ettinger B, Black D, Mitlak B, Knickerbocker R, Nickelsen T, Genant H . Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999; 282(7):637-45. DOI: 10.1001/jama.282.7.637. View

ODonnell S, Cranney A, Wells G, Adachi J, Reginster J . Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Syst Rev. 2006; (3):CD005326. DOI: 10.1002/14651858.CD005326.pub2. View

Bischoff-Ferrari H, Dietrich T, Orav E, Hu F, Zhang Y, Karlson E . Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr. 2004; 80(3):752-8. DOI: 10.1093/ajcn/80.3.752. View

Bliuc D, Nguyen N, Nguyen T, Eisman J, Center J . Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res. 2013; 28(11):2317-24. DOI: 10.1002/jbmr.1968. View

Harris S, Watts N, Genant H, McKeever C, Hangartner T, Keller M . Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999; 282(14):1344-52. DOI: 10.1001/jama.282.14.1344. View

Daly R, Gagnon C, Lu Z, Magliano D, Dunstan D, Sikaris K . Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf). 2011; 77(1):26-35. DOI: 10.1111/j.1365-2265.2011.04320.x. View

10.

Sambrook P, Cameron I, Chen J, Cumming R, Durvasula S, Herrmann M . Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos Int. 2011; 23(2):615-24. DOI: 10.1007/s00198-011-1590-5. View

11.

Gianoudis J, Bailey C, Ebeling P, Nowson C, Sanders K, Hill K . Effects of a targeted multimodal exercise program incorporating high-speed power training on falls and fracture risk factors in older adults: a community-based randomized controlled trial. J Bone Miner Res. 2013; 29(1):182-91. DOI: 10.1002/jbmr.2014. View

12.

Bolland M, Grey A, Avenell A, Gamble G, Reid I . Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011; 342:d2040. PMC: 3079822. DOI: 10.1136/bmj.d2040. View

13.

Zhao R, Zhao M, Xu Z . The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis. Osteoporos Int. 2015; 26(5):1605-18. DOI: 10.1007/s00198-015-3034-0. View

14.

Black D, Reid I, Boonen S, Bucci-Rechtweg C, Cauley J, Cosman F . The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2011; 27(2):243-54. PMC: 3427916. DOI: 10.1002/jbmr.1494. View

15.

Lewis J, Calver J, Zhu K, Flicker L, Prince R . Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res. 2010; 26(1):35-41. DOI: 10.1002/jbmr.176. View

16.

Iuliano-Burns S, Saxon L, Naughton G, Gibbons K, Bass S . Regional specificity of exercise and calcium during skeletal growth in girls: a randomized controlled trial. J Bone Miner Res. 2003; 18(1):156-62. DOI: 10.1359/jbmr.2003.18.1.156. View

17.

Li K, Kaaks R, Linseisen J, Rohrmann S . Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study.... Heart. 2012; 98(12):920-5. DOI: 10.1136/heartjnl-2011-301345. View

18.

Watts N, Chines A, Olszynski W, McKeever C, McClung M, Zhou X . Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int. 2007; 19(3):365-72. DOI: 10.1007/s00198-007-0460-7. View

19.

Bell K, Hayen A, Macaskill P, Irwig L, Craig J, Ensrud K . Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ. 2009; 338:b2266. PMC: 3272655. DOI: 10.1136/bmj.b2266. View

20.

Ringe J, Doherty J . Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat. Rheumatol Int. 2009; 30(7):863-9. DOI: 10.1007/s00296-009-1311-y. View